Search research articles
Contact Us
Filters
Showing results (151-160 of 162) with videos related to
Page
of 17
Sort By:
Journal of Hypertension
|
October 8, 2021
Risk factors predisposing to acute stroke in India: a prospective study
C Venkata S Ram, Sudhir Kumar, Pushpendra Nath Renjen, et al.
Journal of Medicinal Chemistry
|
June 12, 2013
Design, synthesis, and biological evaluation of (E)-N-aryl-2-arylethenesulfonamide analogues as potent and orally bioavailable microtubule-targeted anticancer agents
M V Ramana Reddy, Muralidhar R Mallireddigari, Venkat R Pallela, et al.
The American Journal of Cardiology
|
January 17, 2022
Management of American Heart Association/American College of Cardiology-Defined Stage 2 Hypertension by Cardiologists in India
C Venkata S Ram, Jamshed Dalal, Dhiman Kahali, et al.
Nature Communications
|
August 4, 2021
Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant disease
Katsutoshi Sato, Amol A Padgaonkar, Stacey J Baker, et al.
Cancers
|
October 6, 2020
Blocking c-MET/ERBB1 Axis Prevents Brain Metastasis in ERBB2+ Breast Cancer
Shailendra K Gautam, Ranjana K Kanchan, Jawed A Siddiqui, et al.
European Heart Journal
|
August 31, 2022
The collateral damage of COVID-19 to cardiovascular services: a meta-analysis
Ramesh Nadarajah, Jianhua Wu, Ben Hurdus, et al.
Journal of Medicinal Chemistry
|
January 15, 2014
Discovery of 8-cyclopentyl-2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidine-6-carbonitrile (7x) as a potent inhibitor of cyclin-dependent kinase 4 (CDK4) and AMPK-related kinase 5 (ARK5)
M V Ramana Reddy, Balireddy Akula, Stephen C Cosenza, et al.
Bioorganic & Medicinal Chemistry
|
January 15, 2016
Discovery of 2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one (7ao) as a potent selective inhibitor of Polo like kinase 2 (PLK2)
M V Ramana Reddy, Balireddy Akula, Shashidhar Jatiani, et al.
Journal of Hypertension
|
September 2, 2022
Renal denervation in the antihypertensive arsenal - knowns and known unknowns
Franz H Messerli, Chirag Bavishi, Jana Brguljan, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
December 18, 2013
Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension
Michael A Weber, Ernesto L Schiffrin, William B White, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 162) with videos related to
Sort By:
Page
of 17
Journal of Hypertension
|
October 8, 2021
Risk factors predisposing to acute stroke in India: a prospective study
C Venkata S Ram, Sudhir Kumar, Pushpendra Nath Renjen, et al.
Journal of Medicinal Chemistry
|
June 12, 2013
Design, synthesis, and biological evaluation of (E)-N-aryl-2-arylethenesulfonamide analogues as potent and orally bioavailable microtubule-targeted anticancer agents
M V Ramana Reddy, Muralidhar R Mallireddigari, Venkat R Pallela, et al.
The American Journal of Cardiology
|
January 17, 2022
Management of American Heart Association/American College of Cardiology-Defined Stage 2 Hypertension by Cardiologists in India
C Venkata S Ram, Jamshed Dalal, Dhiman Kahali, et al.
Nature Communications
|
August 4, 2021
Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant disease
Katsutoshi Sato, Amol A Padgaonkar, Stacey J Baker, et al.
Cancers
|
October 6, 2020
Blocking c-MET/ERBB1 Axis Prevents Brain Metastasis in ERBB2+ Breast Cancer
Shailendra K Gautam, Ranjana K Kanchan, Jawed A Siddiqui, et al.
European Heart Journal
|
August 31, 2022
The collateral damage of COVID-19 to cardiovascular services: a meta-analysis
Ramesh Nadarajah, Jianhua Wu, Ben Hurdus, et al.
Journal of Medicinal Chemistry
|
January 15, 2014
Discovery of 8-cyclopentyl-2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidine-6-carbonitrile (7x) as a potent inhibitor of cyclin-dependent kinase 4 (CDK4) and AMPK-related kinase 5 (ARK5)
M V Ramana Reddy, Balireddy Akula, Stephen C Cosenza, et al.
Bioorganic & Medicinal Chemistry
|
January 15, 2016
Discovery of 2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one (7ao) as a potent selective inhibitor of Polo like kinase 2 (PLK2)
M V Ramana Reddy, Balireddy Akula, Shashidhar Jatiani, et al.
Journal of Hypertension
|
September 2, 2022
Renal denervation in the antihypertensive arsenal - knowns and known unknowns
Franz H Messerli, Chirag Bavishi, Jana Brguljan, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)
|
December 18, 2013
Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension
Michael A Weber, Ernesto L Schiffrin, William B White, et al.
Page
of 17